Ditchcarbon
  • Contact
  1. Organizations
  2. Ceva Sante Animale
Public Profile
Pharmaceutical Preparation Manufacturing
FR
updated 16 days ago

Ceva Sante Animale Sustainability Profile

Company website

Ceva Santé Animale, a leading global player in the animal health industry, is headquartered in France and operates extensively across Europe, Asia, and the Americas. Founded in 1999, the company has rapidly established itself as a key provider of innovative veterinary products and services, focusing on both companion and livestock animals. Ceva's core offerings include vaccines, pharmaceuticals, and nutritional products, all designed to enhance animal health and welfare. What sets Ceva apart is its commitment to research and development, ensuring that their solutions are not only effective but also tailored to meet the evolving needs of the market. With a strong emphasis on sustainability and animal welfare, Ceva Santé Animale has achieved significant milestones, positioning itself as a trusted partner in the veterinary community.

DitchCarbon Score

How does Ceva Sante Animale's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

41

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Ceva Sante Animale's score of 41 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.

61%

Let us know if this data was useful to you

Ceva Sante Animale's reported carbon emissions

In 2023, Ceva Santé Animale reported total carbon emissions of approximately 280,125,000 kg CO2e. This figure includes about 61,773,000 kg CO2e from Scope 1 and 2 emissions, while Scope 3 emissions accounted for approximately 218,352,000 kg CO2e, with 114,016,000 kg CO2e attributed to purchased goods and services. Comparatively, in 2022, the company recorded total emissions of about 250,397,000 kg CO2e, with Scope 1 and 2 emissions at approximately 55,746,000 kg CO2e and Scope 3 emissions at around 194,937,000 kg CO2e. This indicates a rise in emissions from 2022 to 2023, highlighting the need for enhanced climate action. Ceva Santé Animale has not disclosed specific reduction targets or initiatives as part of its climate commitments, nor does it appear to have cascaded data from a parent organization. The absence of defined reduction strategies suggests a potential area for improvement in their sustainability efforts. Overall, while Ceva Santé Animale has made strides in reporting its emissions, the lack of reduction targets and initiatives may limit its effectiveness in addressing climate change.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202120222023
Scope 1
-
-
-
Scope 2
-
-
-
Scope 3
-
000,000,000
000,000,000

How Carbon Intensive is Ceva Sante Animale's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Ceva Sante Animale's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Ceva Sante Animale's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Ceva Sante Animale is in FR, which has a very low grid carbon intensity relative to other regions.

Ceva Sante Animale's Scope 3 Categories Breakdown

Ceva Sante Animale's Scope 3 emissions, which increased by 12% last year and increased by approximately 12% since 2022, demonstrating supply chain emissions tracking. Their carbon footprint includes supplier sustainability and value chain emissions data across Scope 3 categories, with "Purchased Goods and Services" being the primary emissions source at 52% of Scope 3 emissions.

Top Scope 3 Categories

2023
Purchased Goods and Services
52%

Ceva Sante Animale's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Ceva Sante Animale has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Ceva Sante Animale's Emissions with Industry Peers

Zoetis

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Boehringer Ingelheim Animal Health USA Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Cargill

US
•
Food products nec
Updated 4 days ago

Boehringer Ingelheim Animal Health do Brasil Ltda.

BR
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

MSD Animal Health

GB
•
Chemicals nec
Updated 2 months ago

Boehringer Ingelheim International GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy